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Abstract 
Background: Care home residents are frequently transferred to hospital, rather than provided 
with appropriate and timely specialist care in the care home.  
Aim: To determine if a model of care providing specialist palliative care in care homes, 
called Specialist Palliative Care Needs Rounds, could reduce length of stay in hospital.  
Design: Stepped wedge randomised control trial. The primary outcome was length of stay in 
acute care (over 24 hours duration), with secondary outcomes being the number and cost of 
hospitalisations. Care homes were randomly assigned to cross-over from control to 
intervention using a random number generator; masking was not possible due to the nature of 
the intervention. Analyses were by intention to treat. The trial was registered with ANZCTR: 
ACTRN12617000080325. Data were collected between 1st February 2017 and 30th June 2018 
Setting/participants: 1700 residents in 12 Australian care homes for older people. 
Results: Specialist Palliative Care Needs Rounds led to reduced length of stay in hospital 
(unadjusted difference: 0.5 days; adjusted difference 0.22 days with 95% C.I. -0.44, -0.01 and 
p=0.038). The intervention also provided a clinically significant reduction in the number of 
hospitalisations by 23%, from 5.6 to 4.3 per facility-month. A conservative estimate of 
annual net cost-saving from reduced admissions was AUD$1,759,011 (US$1·3m; 
UK£0·98m).  
Conclusion: The model of care significantly reduces hospitalisations through provision of 
out-reach by specialist palliative care clinicians. The data offer substantial evidence for 
Specialist Palliative Care Needs Rounds to reduce hospitalisations in older people 
approaching end of life, living in care homes.  
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What is already known about the topic?  
 There is a paucity of robust studies examining models of delivering palliative care in 
residential care homes for older people.  
 Care home residents often have multiple morbidities, and mortality often occurs 
within a year of admission.  
 Access to specialist palliative care provision is often inadequate, and residents risk 
experiencing unnecessary hospitalisations. 
What this paper adds 
 Palliative Care Needs Rounds are triage meetings with care home staff and specialist 
palliative care clinicians, focusing on residents at risk of dying without a plan in 
place. 
 This study demonstrates that Palliative Care Needs Rounds substantially reduce the 
number and length of hospitalisations of care home residents. 
 This is the first fully powered robust study of the model of care. 
Implications for practice 
 The approach supports people to avoid hospitalisation by proactive management of 
symptoms and capability development in staff.  
 Adopting the model of care can lead to substantial cost savings for acute care.  
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Background 
Older people living in residential care (hereafter ‘care homes’) often die within months of 
admission1,2 due to frailty or complex multiple morbidities.3 Care home residents (hereafter 
‘residents’) often experience multiple admissions to hospital prior to their death,4 despite 
some admissions being preventable.5 Hospital admissions are costly and may prompt futile or 
burdensome interventions.6 In Australia, 9-11% of hospitalisations (around 200,000) for older 
people were for people living in, or discharged to, care homes.7 
A core outcome for services providing specialist palliative care in care homes is to decrease 
hospitalisations,8 since acute care admissions are not proven to improve symptom 
management or quality of life, and indeed for people with dementia may exacerbate cognitive 
decline.9 However, admissions are not always avoidable for care home residents, and 
shortening the duration of hospitalisations is an important aspect of limiting the potential 
negative sequelae of these stays. Reducing avoidable admissions and decreasing duration 
involves recognising deterioration and dying, anticipatory planning and documenting 
preferences for hospitalisation, which is predicated on staff having sufficient death literacy 
(the ability to talk and then act on discussions about death and dying, such as through 
advance care planning or goals of care discussion) to engage with residents and families 
about end of life care. Staff education therefore plays an important role in improving end of 
life care in care homes,10 and is also a core element of the international PACE study seeking 
to increase basic palliative care provision into care homes.11 
Many residents will require specialist palliative care to manage complex symptoms12 to avoid 
hospitalisation at end of life. Yet there is limited robust evidence to support specific models 
of delivery in care homes13 resulting in an urgent need to develop and test methods of 
improving the care of residents in their last months of life.  
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This intervention draws together a number of recognised requirements for looking after older 
people in care, offering micro and meso-level interventions.14 First, care home staff wish to 
reduce preventable hospitalisations, yet often lack clear methods of doing so.15 Second, 
increasing anticipatory planning (including Advance Care Plans – and anticipatory 
prescribing) improves the confidence of residential care staff to discuss goals of care and 
leads to a reduction in hospitalisations.16 Further, care home nurses who are supported to 
administer anticipatory medications reduce hospital admissions and facilitate faster symptom 
management.17 Provision of support and education to care home staff improves end of life 
care for residents,18 if provided in conjunction with other interventions.19 The development of 
the Specialist Palliative Care Needs Rounds (hereafter ‘Needs Rounds’) model of care arose 
from an attempt to meet these care requirements to deliver the desired outcomes for both care 
home staff and residents. Care homes in Australia are staffed primarily by nursing aides, with 
a small number of registered nurses, for people who need continuous supported care and can 
no longer live at home. The majority of care homes have long-term residents with high needs 
and low functional ability, and a small number of respite beds. We conducted a quasi-
experimental pilot study of Needs Rounds in four care homes (comparing residents with a 
matched, decedent control group) and demonstrated decreased length of hospitalizations, 
increased residents dying in their preferred place20 and enabled staff to normalize death and 
dying21 by adopting an out-reach model of specialist palliative care. The current study sought 
to establish, through a robust prospective trial, whether the model of care reduces length of 
stay in acute care as the primary outcome, and number/cost of hospitalisation. 
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Methods 
Study design and participants 
We applied a prospective stepped wedge cluster randomised control trial. The study protocol 
is available from the corresponding author. Stepped wedge was adopted as the most 
acceptable trial design as it avoided the moral concerns of a two arm trial given the efficacy 
of the model during pilot testing, and those of a wait-list control design due to the limited 
expected survival of residents.22 The design also allowed for management of clinicians’ 
workload through sequential roll-out. Individuals were followed across both control and 
intervention phases. Masking of sites was not possible because it was not feasible to blind 
staff administering the intervention.  
Facilities were eligible for inclusion if they were a care home for older people in the 
Australian Capital Territory. Twenty-six such facilities were in operation at commencement 
of the trial. Four facilities were excluded because they had been used in the pilot study, and 
were therefore considered contaminated. A further facility was excluded because it was used 
as a training site. The remaining 21 facilities were invited to participate; 12 opted into the 
trial, all of which were included. All residents in each facility were included in the sample 
and included in analyses, with the exception of respite residents, who were often transient. 
 
Randomisation and masking 
Care homes were randomised to one of five clusters. Randomisation was performed by a 
researcher independent of the trial’s assessment and delivery. Randomisation at the level of 
care home was to avoid contamination of staff exposure to the intervention if randomisation 
had occurred at the individual level. Simple randomisation was used, with sites allocated a 
unique code at the outset of the project. Sequence generation was managed through an 
internet-based programme which randomly selected sites for each step. Once randomisation 
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was conducted, sites were informed of the timing of their facility’s migration from control to 
intervention condition by the study’s chief investigator.  
 
Intervention description 
The specialist palliative care intervention consisted of direct support (clinical work with 
residents) and indirect support in the form of ‘Needs Rounds’ which have been described in 
detail elsewhere, including a checklist to guide practice (included in the supplementary 
files).23 Needs Rounds are monthly 60 minute triage meetings, where up to ten residents who 
are at greatest risk of dying without a plan in place and who have a high symptom burden are 
discussed. Risk stratification and case-finding was the theoretical model underpinning the 
intervention24,25 to promote equitable and efficient distribution of specialist palliative care 
services. Hence care home staff are asked to prioritise residents for discussion in Needs 
Rounds who, for example, have been transferred from hospital while actively dying, or where 
staff would not be surprised if the resident died within six months. Needs rounds integrate 
case-based education, with each resident’s bio-psycho-social status discussed to promote 
symptom management and identify opportunities to reinforce and extend staff knowledge. 
Discussion of residents at Needs Rounds frequently led to initiating case conferences 
(attended by the resident, GP, and care home staff), completion of advance care planning 
with resident input, management of current and anticipatory medicines, and identifying 
legally appointed alternate decision makers. Prior to commencement of the Needs Rounds, 
staff at each site were provided with a briefing regarding the aims of the model of care and 
practicalities of how it would function, including recommendation to develop a system for 
identifying residents to discuss. Site briefing notes are available from the corresponding 
author.  Needs Rounds were run by specialist palliative care staff (two nurse practitioners and 
a clinical nurse consultant, who had access to advice from palliative medicine specialists for 
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clinical decision making). All trial clinicians were based in the city’s specialist palliative care 
unit that provides outreach to care homes and provided the intervention face-to-face with care 
home staff. Care home staff attending Needs Rounds included registered nurses, enrolled 
nurses, nursing aides, activities coordinators and managers.  
  
The control condition involved usual care, which consisted of the specialist palliative care 
clinicians providing ad-hoc reactive clinical consultations when referred by facility staff.   
The research team monitored all sites for fidelity to the intervention, grading them with a 3-
tier rating system, namely low, moderate, and high fidelity. Fidelity was assessed by two 
methods. First, a random sample of 20% of all audio-recorded Needs Rounds were assessed 
for adherence to the Needs Rounds Checklist.23 Second, feedback from the specialist 
palliative care clinicians was assessed regarding site buy-in to the model of care, for example 
engagement in organising case conferences, and take up of actions following Needs Rounds. 
Two of the sites had very poor fidelity to the intervention procedures. Fidelity ratings are 
shown in a supplementary file, alongside the TIDieR checklist for reporting interventions. 
 
Procedure 
The intervention commenced with two sites on 11th April 2017. Other sites crossed over from 
control bi-monthly in clusters of two or three. The last two sites crossed-over on 7th 
December 2017, with follow-up on all sites occurring monthly until cessation of data 
collection on 30th June 2018. Different cluster sizes reflected pragmatic constraints of 
clinicians’ workloads throughout the course of the study. The trial ceased as planned six 
months after the final site received the intervention. New admissions to facilities were 
included in prospective data collection.  
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Ethics committee approvals were obtained from Calvary Public Hospital in Canberra (ref: 44-
2016), National Capital Private Hospital Canberra (ref: 20/2/2017) and the Australian 
Catholic University (ref: 020685). Consent to run the trial was gained at site, rather than 
individual resident, level given the impracticalities of gaining informed consent from a large 
population (1700 people) many of whom were likely to have substantial cognitive 
impairment (with few appointed medical power of attorneys at commencement), with low 
risk to participants, and sufficient protection of participant privacy. This follows national 
guidelines for Australia from the NHMRC.26 The trial was registered with ANZCTR: 
ACTRN12617000080325, on 16-1-2017 prior to enrolment of first residents. No 
methodological changes were made after study commencement. Facilities were encouraged 
to report any adverse outcomes/harms to the research team.  
 
 
Outcomes 
The primary outcome was length of stay in hospital for care home residents. Length of stay 
was preferred over hospitalisation, since some hospitalisations are not preventable (for 
example a broken hip). Reducing length of stay decreases risks of iatrogenic harm, including: 
delirium, infection, cognitive and physical decline, futile or burdensome interventions, and 
the risk of dying in hospital.6,7  
 
Length of stay was calculated for those residents who were hospitalised for longer than 24 
hours,27 including those who died during the hospitalisation. Residents who were hospitalised 
for less than 24 hours were excluded from length of stay analyses (as their length of stay was 
considered as 0 days). All hospitalisations were recorded and reported for analysis. Data on 
hospitalisations were gathered by facility administrators and academic researchers from 
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residents’ care home files, and hospital discharge summaries in a bespoke spreadsheet. 
Demographic and clinical data included age, sex, admission and discharge date, whether they 
died during hospital admission, primary diagnosis and comorbidities, presence of an advance 
care plan, health directive and medical power of attorney documentation.  
Secondary outcomes included overall number and cost of admissions (reported below). Other 
outcomes including quality of death, staff confidence and place of death, are reported 
elsewhere.28 Two months of baseline data collection occurred in all sites. 
 
Statistical and cost analysis  
The sample size was estimated taking into consideration of the study design as a stepped-
wedge randomised trial, with the primary outcome as length of hospitalisation when 
participants are admitted to the hospital. Results obtained from the pilot study suggested that 
the intervention could achieve a moderate effect size of 0.6 with a means difference in LOS 
of 1.8 days (pooled S.D.=2.9). 
The sample size was derived initially from a two-arm randomised control design with 1:1 
allocation ratio, whereby an unadjusted sample of about 41 residents in each arm would 
provide 80% power at a 2-tail significance level of 5% with an intervention effect size of 0.6. 
The calculation was then adjusted for the stepped wedge design,29 with the design effect 
calculated as 4.55, and a minimum total of 410 hospitalised residents required, recognising 
that a larger sample would offer greater analytic power. 
Generalised Linear and Latent Mixed Model was used to analyse length of stay, to manage 
the fact that patients could have been hospitalised multiple times in the control and 
intervention phases. This approach is able to incorporate the clustering effect of repeated 
measures from individual patients nested in different sites, the duration of exposure, as well 
as the variabilities among patients across various sites. In the regression model, we included 
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the residents’ demographics, characteristics, the level of fidelity to the intervention procedure 
(1, 2, and 3, representing low, moderate, and high fidelity, respectively) and duration of 
exposure” 
Analysis was conducted by intention-to-treat, and not by denominator (of those discussed at 
Needs Rounds) since the intervention’s education component was hypothesised to impact 
potentially all residents not just those discussed. 
Logistic regression could not be conducted on the likelihood of hospitalisation. Under the 
data structure, all non-hospitalised residents would be given a value of 0 under the logistic 
regression framework across both control and intervention phases irrespective of the time 
spent in both phases. This means that there is no variation for all non-hospitalised residents in 
the data. Consequently, analysis of length of stay used Generalised Linear and Latent Mixed 
Model with ‘negative binomial’ being the link function for the model. 
The cost analysis was calculated by comparing the difference in total overnight stays in 
hospital between control and intervention phase. Adjustment was made to accommodate the 
difference of time spent in the control phase (74 facility-months) and intervention phase (124 
facility-months). 
The hospital bed cost was calculated based on the most recent National Hospital Cost Data 
Collection Cost Report 2015-2016.30 The bed day costs were calculated using the sub-acute 
bed day rate for geriatric evaluation and management of AUD$1,286 (US$915).  
 
Results 
Residents were recruited from 12 sites with a total sample size of 1700, of whom 567 were 
discussed in Needs Rounds. Figure 1 illustrates flow through the trial. A small number of 
residents (n=11) migrated from one cluster to another during the study period. Only one 
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resident moved between clusters that were in different phases of the trial (i.e. moved from 
control cluster to intervention). Consequently, the impact of such migration across cluster on 
the analyses was negligible. One site withdrew at month 12 citing a mismatch with their 
preferred reactive, rather than proactive, model of care.  
Sites spent a total of 74 months in control condition and 124 months in intervention, as 
shown in Figure 1 (last page of document).  
 
Table 1 illustrates the characteristics of residents (and the Supplementary materials S1 
presents further site description). Table 2 shows hospitalisations by phase of trial. In total, 
there were 1149 hospital encounters, of which 943 were hospital admissions of >24 hours. Of 
these hospital admissions, 415 (44%) were in the control phase, with 528 in the intervention 
phase. There were 88 and 123 hospitalisations of <24 hours in the control and intervention 
phases respectively. Many residents had multiple admissions, as expected in this population, 
with 377 residents having only one admission. Of the 211 residents who were admitted more 
than once, 137 had two admissions, 45 had three admissions, 11 had four admissions, and 18 
had more than four admissions.  
 
The primary outcome - length of stay - reduced in the intervention phase by 23%, from 5·6 to 
4·3 days per facility month. The total hospital bed days per facility-month was reduced by 
31% from 39 to 27. That is, the model of care led to fewer residents using acute care services, 
as illustrated in Figure 2.  
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Table 1. Descriptive information on the residents 
 
Baseline at Step 0  
(n = 1089) 
Full sample 
(n = 1700) 
Patients' Characteristics Mean [S.D.] or n (%) Mean [S.D.] or n (%)  
   
Age 85 [9.1] 85 [8.8] 
   65 25 (2.3%) 34 (2%) 
   66-80 252 (23%) 402 (24%) 
   81-99 782 (71%) 1219 (72%) 
   100 24 (2.2%) 33 (1.9%) 
Male  362 (33%) 613 (36%) 
Medical power of attorney  724 (67%) 1180 (71%) 
Health Direction 22 (2.0%) 59 (3.6%) 
Advance Care Plan 460 (44%) 680 (42%) 
Primary Diagnosis    
    Dementia/Parkinson  396 (36%) 579 (34%) 
    Cancer  32 (2.9%) 78 (4.6%) 
    Cardiovascular Disease  150 (14%) 219 (13%) 
    Frail aged  103 (9.5%) 128 (7.5%) 
    Organ Failure  36 (3.3%) 57 (3.4%) 
    Others 372 (34%) 638 (38%) 
Age-adjusted Charlson Comorbidity Index 5.4 [1.5] 5.4 [1.5] 
   
 
 
Figure 2: Hospital bed days and admissions by phase of trial 
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The unadjusted average length of stay for residents in the intervention phase and control 
phase were 6.4 days (s.d.=8.3) and 6.9 days (s.d.=9.1) respectively. After adjusting for 
demographics, resident characteristics, fidelity and duration of exposure, the Generalised 
Linear Latent Mixed Model the intervention reduced length of stay by 0.22 days (95% CI: -
0.44, -0.01; p=0.038) (Table 2). The results were driven by sites with high and moderate 
fidelity to the intervention, where length of stay was reduced by 0.26 days (95% CI: -0.46, -
0.05; p=0.015) in these sites (Table 3). 
Table 2. Descriptive information on the hospitalisation of residents by phases 
 Control Intervention 
   
No. of hospital admissions (>24 hours) 415 528 
No. of presentations to hospital (<24 hours) 83 123 
Minimal number of hospitalisation 1 1 
Maximum number of hospitalisation 18 14 
Total bed days 2876 3385 
No. of admissions per facility-month 5.6 4.3 
No. of presentations per facility-month 1.1 1.0 
Total bed days per facility-month 39 27 
Total deaths  234 303 
 
Table 3. Length of hospital stays for those admitted and discharged by phases and fidelity  
 
 
LOS (days)  
For those admitted and discharged Resultsa 
 Control Intervention 
 
Unadj. 
Mean 
SD 
Unadj. 
Mean 
SD 
Treatment 
Effect  
95% CI p value 
        
Full sample 6.9 9.1 6.4 8.3 -0.22 [-0.44, -0.01] 0.038 
Sites by fidelity rating        
   High/Moderate 6.7 9.1 6.5 8.7 -0.26 [-0.46, -0.05] 0.015 
   Low  9.4 9.6 5.4 6.1 -0.08 [-0.57, 0.41] 0.737 
        
a Adjusted for age, sex, medical power of attorney, health directive, Advance Care Plan/statement of choices, 
Primary diagnosis, and age-adjusted Charlson Comorbidity index. For the full sample, we adjusted for fidelity to 
the model.  
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Cost calculation 
Bed day costs were calculated at $1,286 per day. The total number of bed days during the 74 
facility-months of the control phase was 2,876. The corresponding number during the 
intervention phase was 3,385 over a period of 124 facility-months of exposure to the new 
model of care.   
Given the total time spent in each phase, the reduction of bed days for each facility-month 
was: 2,876/74 –3,385/124 = 11.56. This yields an average monthly cost saving of $14,866 per 
facility. 
 
This model of care was delivered by senior nurses, employed as nurse practitioners or clinical 
nurse consultant. To report a net cost-saving, maximum staffing during the trial is based on 
two full time nurse practitioners, where annual salaries (plus on-cost) were approximately 
$381,716.  Consequently, the overall annual estimated net cost-saving across 12 sites was 
$1,759,011 (12 monthly savings of $14,866  12 sites, minus annual staffing of $381,716). 
 
No harms, adverse events or unintended consequences were reported.  
Discussion 
Main findings 
Needs Rounds offer a robust proactive approach to reducing length of stay in hospital and 
number of hospitalisations, by focusing on those with greatest symptom burden, providing 
specialist clinical care, education and anticipatory planning, including access to medications 
needed at end of life.  
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Preventing inappropriate admissions to acute care,31 or reducing length of stay where possible 
fits, with quality clinical practice goals for care home residents,4,15 for example, facilitating 
people to die in their preferred place of the care home, rather than in hospital.20 
Our model focuses on people with the most complex care needs, who by virtue of their 
residence in care are likely to be approaching end of life. Consequently, this intervention is 
better tailored to care home residents than other interventions which focus on care 
coordination,32 or primary palliative care.33 This intervention is also flexible to the changing 
needs of care homes and their staff. The degree of focus on different components of Needs 
Rounds, such as staff education, and the determination of when specialist clinical input is 
required, is dynamic allowing responsiveness to local context. This is of particular utility due 
to the known high-turnover of care home staff, the related difficulties in maintaining care 
practices,34 and jurisdictional differences in determining the role and availability of specialist 
palliative care in care homes.32  
 Demographic trends of increasing numbers of older people35 demand increased focus on 
services which meet the clinical complexities of older people, including end of life and 
palliative care. Risk stratification which underpins the implementation of Needs Rounds is 
essential in effective stewardship of hospital and specialist palliative care resources.24 The 
cost savings are substantial and represents a cost-effective mechanism for governments to 
invest in Needs Rounds to reduce acute care costs.36  
 
Since sites with higher fidelity reported greater outcomes, adherence to the model is 
important in achieving reduced hospitalisations, requiring sites to run monthly Needs 
Rounds, have care home cultures that support staff engagement with Needs Rounds and 
specialist palliative care staff who adhere to the checklist.23  
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Since addressing the healthcare needs of ageing populations is of international concern, we 
purposefully developed the checklist that guides Needs Rounds to be suitable to use across 
organisations and countries23 to allow for greatest uptake of the approach. Nursing care 
homes for older people do not differ substantially between developed nations; most support a 
frail, older population, operate often as sub-acute units and struggle to retain their staff, many 
of whom are ethnic minorities with limited tertiary education. Consequently, the model of 
care can be adopted internationally to reduce hospitalisations of care home residents.  
 
Critically, since hospitalizations often have iatrogenic consequences,15,37 this model of care 
can substantially improve the quality of life for residents in their final months of life.  
 
Limitations 
This is the first high quality, fully powered, cluster trial demonstrating substantial impacts on 
the number and duration of hospitalisations, among older people living in residential care, 
and is thus a substantial contribution to a sparse evidence base.13  
Our study had some limitations. While demonstrating a statistically significant reduction in 
hospitalisations, there is no international standard of a clinically significant reduction in 
admissions. The effect size may be small, yet is based on all residents not just the 
denominator of those discussed at Needs Rounds (in line with the analytic principle of 
intention-to-treat and the assumption that the education provided would impact wider clinical 
practice, not just for those residents discussed). The cost calculations reflect day rates for sub-
acute beds, and thus underestimate the total savings as it excludes treatment costs, acute bed 
use and transfer (ambulance) costs. The dose effect of the intervention and its impact on cost 
savings has not been calculated. Cost savings may not continue at a linear rate; benefits may 
plateau or be less powerful in facilities which already had high quality anticipatory planning 
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for all residents. Masking of sites was not possible. Facilities varied in their engagement and 
fidelity with the intervention, with consequent impact on outcomes. Yet the implementation 
challenges reflect real-world working dynamics where facility cultures may ease or hinder the 
adoption of new models of care. Some residents had received inpatient specialist palliative 
care admissions but the data collected did not allow for granular reporting of these episodes. 
Needs Rounds are likely to have reduced the number of inpatient palliative care admissions, 
since staff were able to care for residents within the facility rather than refer them out.  
Conclusion 
Despite its limitations, this study is the largest trial to date (12 facilities with 1700 residents) 
to assess the effectiveness of Needs Rounds in reducing length of stay in hospital and number 
of admissions. There are direct cost-savings in reduced admissions and further potential 
savings in reducing ambulance usage in hospital transfers and post hospital care. The trial is 
strengthened by the stepped-wedge design which managed possible site-level effects. Needs 
Rounds are easy to implement, and the approach can be used internationally to enable care 
home residents to live well until they die.  
  
 18 
 
Declarations 
 
Author contributors 
LF designed the study’s methodology. LF was the Chief Investigator for the study. LF, JK 
were responsible for study administration and management, and all authors were involved in 
ongoing implementation, data collection or data cleaning. LL and WL analysed the data. LL, 
WL, LF and JK interpreted the data. LF and JK wrote the first draft of the manuscript. All 
authors revised it critically for important intellectual content. All authors read and approved 
the final manuscript.  
 
Funding 
This study was funded by the Australian Capital Territory (ACT) Health Department, who 
played no further role in the study.  
 
Conflict of interest 
We declare no competing interests. 
 
Ethics  
Ethics committee approvals were obtained from Calvary Public Hospital in Canberra (ref: 44-
2016), National Capital Private Hospital Canberra (ref: 20/2/2017) and the Australian 
Catholic University (ref: 020685). Consent to run the trial was gained at site, rather than 
individual resident, level given the impracticalities of gaining informed consent from a large 
population (1700 people) many of whom were likely to have substantial cognitive 
impairment (with few appointed medical power of attorneys at commencement), with low 
 19 
 
risk to participants, and sufficient protection of participant privacy. This follows national 
guidelines for Australia from the NHMRC. 
 
Data sharing 
Individual-level data collected for this study is subject to ethical and privacy restrictions. The 
conditions of ethical approval do not allow us to distribute or make available these data 
directly to other parties. However, the study protocol is available online. Applications for 
data access should be made by contacting the Chief Investigator. Researchers must have their 
study protocol approved by an appropriate research ethics review board.   
 
Acknowledgements  
We thank and acknowledge the staff at all 12 care homes who facilitated access to the data, 
and who engaged in Needs Rounds. We also acknowledge Karemah Francois’s role in data 
collection, Clare Lovell’s role as a study clinician for part of the trial, and Profs Meera Agar 
and Deb Parker for their input in early discussions about the study’s design.  
 
 
 
  
 20 
 
 
Supplementary files (available when published) 
 Table S1: Description of sites  
 Table S2: Rating on the extent of fidelity to the intervention 
 Figure S3: Palliative Care Needs Rounds Checklist 
 CONSORT Stepped Wedge checklist  
 TIDIER checklist  
 
 
  
 21 
 
References 
1. Shah SM, Carey IM, Harris T, DeWilde S, Cook DG. Mortality in older care home residents in 
England and Wales. Age Ageing 2013; 42(2): 209-15. 10.1093/ageing/afs174. 
2. Kinley J, Hockley J, Stone L, et al. The provision of care for residents dying in U.K. nursing 
care homes. Age Ageing 2014; 43(3): 375-9. 10.1093/ageing/aft158. 
3. Kelly A, Conell-Price J, Covinsky K, et al. Length of stay for older adults residing in nursing 
homes at the end of life. J Am Geriatr Soc 2010; 58(9): 1701-6. 10.1111/j.1532-5415.2010.03005.x. 
4. Wilson DM, Shen Y, Birch S. New Evidence on End-of-Life Hospital Utilization for Enhanced 
Health Policy and Services Planning. J Palliat Med 2017; 20(7): 752-8. 10.1089/jpm.2016.0490. 
5. Xing J, Mukamel DB, Temkin-Greener H. Hospitalizations of nursing home residents in the 
last year of life: nursing home characteristics and variation in potentially avoidable hospitalizations. J 
Am Geriatr Soc 2013; 61(11): 1900-8. 10.1111/jgs.12517. 
6. Ouslander JG, Lamb G, Perloe M, et al. Potentially Avoidable Hospitalizations of Nursing 
Home Residents: Frequency, Causes, and Costs. 2010; 58(4): 627-35. doi:10.1111/j.1532-
5415.2010.02768.x. 
7. Australian Institute of Health and Welfare. Movement between hospital and residential aged 
care 2008–09. Data linkage series no. 16. . Canberra: AIHW, 2013. 
8. Cimino NMM, M. L. Evaluating the impact of palliative or hospice care provided in nursing 
homes. Journal of gerontological nursing 2014; 40(10): 10-4.  
9. Dewing J, Dijk S. What is the current state of care for older people with dementia in general 
hospitals? A literature review. 2016; 15(1): 106-24. 10.1177/1471301213520172. 
10. Miller S. Hospice and Palliative Care in Nursing Homes: Challenges and Opportunities for 
Enhanced Access. Rhode Island Medical Journal 2015; 96(1): 26-9.  
11. Smets T, Onwuteaka-Philipsen BBD, Miranda R, et al. Integrating palliative care in long-term 
care facilities across Europe (PACE): protocol of a cluster randomized controlled trial of the ‘PACE 
Steps to Success’ intervention in seven countries. BMC Palliative Care 2018; 17(1): 47. 
10.1186/s12904-018-0297-1. 
12. Kelley AS, Morrison RS. Palliative Care for the Seriously Ill. N Engl J Med 2015; 373(8): 747-
55. 10.1056/NEJMra1404684. 
13. Hall S, Kolliakou A, Petkova H, Froggatt K, Higginson IJ. Interventions for improving palliative 
care for older people living in nursing care homes. The Cochrane database of systematic reviews 
2011; (3): Cd007132. 10.1002/14651858.CD007132.pub2. 
14. Froggatt K, Payne S, Morbey H, et al. Palliative Care Development in European Care Homes 
and Nursing Homes: Application of a Typology of Implementation. J Am Med Dir Assoc 2017; 18(6): 
550.e7-.e14. 10.1016/j.jamda.2017.02.016. 
15. Cohen AB, Knobf MT, Fried TR. Avoiding Hospitalizations From Nursing Homes for Potentially 
Burdensome Care: Results of a Qualitative Study. JAMA Internal Medicine 2017; 177(1): 137-9. 
10.1001/jamainternmed.2016.7128. 
16. Caplan GA, Meller A, Squires B, Chan S, Willett W. Advance care planning and hospital in the 
nursing home. Age Ageing 2006; 35(6): 581-5. 10.1093/ageing/afl063. 
17. Wilson E, Morbey H, Brown J, Payne S, Seale C, Seymour J. Administering anticipatory 
medications in end-of-life care: a qualitative study of nursing practice in the community and in 
nursing homes. Palliative Medicine 2015; 29(1): 60-70.  
18. Seymour J, Kumar A, Froggatt K. Do nursing homes for older people have the support they 
need to provide end-of-life care? A mixed methods enquiry in England. Palliative Medicine 2011; 
25(2): 125-38. 10.1177/0269216310387964. 
19. Froggatt K. Palliative care and nursing homes: where next? Palliative Medicine 2001; 15(1): 
42-8.  
 22 
 
20. Chapman MD, Johnston N, Lovell C, Forbat L, Liu WM. Avoiding costly hospitalisation at end 
of life: Findings from a specialist palliative care pilot in residential care for older adults. BMJ 
Supportive & Pallative Care 2018; 8(1): 102-9.  
21. Johnston N, Lovell C, Liu WM, Chapman MD, Forbat L. Normalising and planning for death in 
residential care: Findings from a qualitative focus group study of a specialist palliative care 
intervention. BMJ Supportive & Pallative Care 2016 early online.  
22. Hemming K, Haines TP, Chilton PJ, Girling AJ, Lilford RJ. The stepped wedge cluster 
randomised trial: rationale, design, analysis, and reporting. BMJ 2015; 350: 391.  
23. Forbat L, Chapman M, Lovell C, Liu WM, Johnston N. Improving specialist palliative care in 
residential care for older people: a checklist to guide practice. BMJ supportive & palliative care 2018; 
8: 347-53. 10.1136/bmjspcare-2017-001332. 
24. Lewis G, Curry N, Bardsley MC. Choosing a predictive risk model: a guide for commissioners 
in England. London: Nuffield Trust, 2011. 
25. Richards DA, Bower P, Pagel C, et al. Delivering stepped care: an analysis of implementation 
in routine practice. Implementation science : IS 2012; 7: 3. 10.1186/1748-5908-7-3. 
26. The National Health and Medical Research Council, The Australian Research Council, 
Universities Australia. The National Statement on Ethical Conduct in Human Research 2007 (updated 
2018) Canberra: Commonwealth of Australia, 2018. 
27. Arendts G, Howard K. The interface between residential aged care and the emergency 
department: a systematic review. Age Ageing 2010; 39(3): 306-12. 10.1093/ageing/afq008. 
28. Liu WM, Koerner J, Lam L, et al. Improved quality of death and dying in care homes: a 
palliative care stepped wedge randomised control trial. Journal of the American Geriatric Society 
2019.  
29. Woertman W, de Hoop E, Moerbeek M, Zuidema SU, Gerritsen DL, Teerenstra S. Stepped 
wedge designs could reduce the required sample size in cluster randomized trials. Journal of clinical 
epidemiology 2013; 66(7): 752-8. 10.1016/j.jclinepi.2013.01.009. 
30. IHPA. National Hospital Cost Data Collection Cost Report: Round 20 Financial Year 2015-16. 
https://www.ihpa.gov.au/publications/national-hospital-cost-data-collection-public-hospitals-cost-
report-round-20-0: Independent Hospital Pricing Authority, 2018. 
31. Cardona-Morrell M, Kim JCH, Brabrand M, Gallego-Luxan B, Hillman K. What is inappropriate 
hospital use for elderly people near the end of life? A systematic review. European journal of internal 
medicine 2017; 42: 39-50. 10.1016/j.ejim.2017.04.014. 
32. Luckett T, Phillips J, Agar M, C. V, Green M, Davidson P. Elements of effective palliative care 
models: a rapid review. BMC health services research 2014; 14: 22.  
33. Hockley J, Kinley J. A practice development initiative supporting care home staff deliver high 
quality end-of-life care. International journal of palliative nursing 2016; 22(10): 474-81. 
10.12968/ijpn.2016.22.10.474. 
34. Lerner NB, Johantgen M, Trinkoff AM, Storr CL, Han K. Are nursing home survey deficiencies 
higher in facilities with greater staff turnover. J Am Med Dir Assoc 2014; 15(2): 102-7. 
10.1016/j.jamda.2013.09.003. 
35. He W, Goodkind D, Kowal P. An Aging World: 2015. International population report. Series 
P95/ 16-1. Washington, DC: U.S. Government Printing Office, 2015. 
36. Australian Capital Territory. Budget 2019-20 Building for the future. Paper 3 Budget Outlook. 
Canberra: ACT Government, 2019. 
37. Schwab C, Korb-Savoldelli V, Escudie JB, et al. Iatrogenic risk factors associated with hospital 
readmission of elderly patients: A matched case-control study using a clinical data warehouse. 2018; 
43(3): 393-400. doi:10.1111/jcpt.12670. 
 
 23 
 
Figure 1: Participant flow 
 
